Elix was picked up in the Chemical Daily on March 18, 2021.

“Elix to build a new revenue model for AI drug discovery, proposing a contract on an inventive fee basis.”

エリックス、ＡＩ創薬で新たな収益モデル構築へ、成功報酬型を提案